UK markets open in 2 hours 20 minutes

OBI Pharma, Inc. (4174.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
60.90-0.80 (-1.30%)
As of 12:15PM CST. Market open.
Currency in TWD

Valuation measures4

Market cap (intra-day) 14.14B
Enterprise value 11.86B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)340.43
Price/book (mrq)3.72
Enterprise value/revenue 2.10k
Enterprise value/EBITDA -8.68

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-24.85%
S&P500 52-week change 326.27%
52-week high 399.30
52-week low 358.00
50-day moving average 362.30
200-day moving average 374.57

Share statistics

Avg vol (3-month) 3388.81k
Avg vol (10-day) 3235.4k
Shares outstanding 5229.25M
Implied shares outstanding 6230.02M
Float 8168.12M
% held by insiders 133.75%
% held by institutions 15.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,642.61%

Management effectiveness

Return on assets (ttm)-21.35%
Return on equity (ttm)-22.83%

Income statement

Revenue (ttm)41.55M
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)3,532.90%
Gross profit (ttm)N/A
EBITDA -1.91B
Net income avi to common (ttm)-1.05B
Diluted EPS (ttm)-4.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.78B
Total cash per share (mrq)12.14
Total debt (mrq)547.11M
Total debt/equity (mrq)11.04%
Current ratio (mrq)19.92
Book value per share (mrq)16.60

Cash flow statement

Operating cash flow (ttm)-1.65B
Levered free cash flow (ttm)-1.23B